Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about MRK

Recent news which mentions MRK

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks
Tickers GILD MRK NEWS
Tags Biotech Benzinga MRK
From Benzinga
After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment
Tickers GILD MRK NEWS
Tags News GILD Top Stories
From Benzinga
Merck Virus Treatment Shows 60.4% Effectiveness, Reduces Certain Infections In Infants
Tickers BIOVF MRK NEWS
Tags News Top Stories General
From Benzinga
Up 700% This Year, Is It Too Late to Invest in This Stock?
Tickers MRK SMMT
Tags MRK Market News SMMT
From Motley Fool
2 Incredibly Cheap Big Pharma Stocks to Buy Now
Tickers MRK PFE
Tags Recent Press Releases Market News PFE
From Motley Fool
A Closer Look at Merck & Co's Options Market Dynamics
Tickers MRK
Tags Benzinga Markets Market News
From Benzinga
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
Tickers ADT AMGN AVGO AZEK
Tags Expert Ideas AZEK JHG
From Benzinga
Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer
Tickers MRK MRNA MYNZ PFE
Tags Market News Benzinga Penny Stocks
From Benzinga
Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'
Tickers ALMS MRK NEWS PEP
Tags Jim Cramer Long Ideas MRK
From Benzinga
Merck's Mumps Vaccine Controversy: Class-Action Lawsuit Alleges Anticompetitive Behavior, Court Shields From Liability
Tickers GSK MRK NEWS
Tags Legal Top Stories News
From Benzinga
Merck Touts Phase 3 Success For $20B Cancer Drug Keytruda In Untreated Head And Neck Cancer Patients
Tickers MRK
Tags MRK Briefs Health Care
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers BMY ELV HIMS HUM
Tags ELV NVCR LLY
From Benzinga
2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts
Tickers MRK SMMT VKTX
Tags Market News VKTX Recent Press Releases
From Motley Fool
Is It Time to Buy September's Worst-Performing Dow Jones Stocks?
Tickers BA DJI JPM MRK
Tags Recent Press Releases ^DJI MRK
From Motley Fool
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Tickers AZN MRK NEWS NVO
Tags Biotech AI Generated MRK
From Benzinga
Could Summit Therapeutics Become the Next Merck?
Tickers MRK SMMT
Tags Market News SMMT Recent Press Releases
From Motley Fool
Demystifying Merck & Co: Insights From 8 Analyst Reviews
Tickers MRK
Tags Analyst Ratings Benzinga BZI/AAR
From Benzinga
Exploring The Competitive Space: Merck &amp; Co Versus Industry Peers In Pharmaceuticals
Tickers MRK NEWS
Tags News Markets Trading Ideas
From Benzinga
The Covid Era Tech Promises To Reinvent Cancer Treatment
Tickers MRK MRNA MYNZ PFE
Tags Penny Stocks PFE General
From Benzinga
2 High-Potential Growth Stocks You Shouldn't Overlook
Tickers LUNR MRK SMMT
Tags MRK Recent Press Releases SMMT
From Motley Fool
Is Merck Stock a Buy?
Tickers MRK
Tags MRK Recent Press Releases Market News
From Motley Fool
Evaxion Biotech Partners With Merck To Expand Vaccine Development
Tickers EVAX MRK NEWS
Tags News Top Stories General
From Benzinga
This Is What Whales Are Betting On Merck & Co
Tickers MRK
Tags MRK Options BZI/UOA
From Benzinga
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
Tickers BGNE BMY MRK NEWS
Tags BGNE Biotech Health Care
From Benzinga
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
Tickers LLY MRK NEWS
Tags Health Care MRK Benzinga
From Benzinga
Merck's Experimental Favezelimab/Keytruda Combo Fails In Late-Stage Colorectal Cancer Study
Tickers MRK NEWS
Tags Top Stories News Market News
From Benzinga
Merck & Co Unusual Options Activity For September 23
Tickers MRK
Tags Markets Benzinga Market News
From Benzinga
Pfizer Advances On Its Cancer Journey
Tickers MRK MRNA MYNZ PFE
Tags Biotech contributors MYNZ
From Benzinga
Is It Too Late to Buy ServiceNow Stock?
Tickers IT MRK NOW STLA
Tags Market News Recent Press Releases STLA
From Motley Fool
Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer
Tickers MRK NEWS
Tags Stories That Matter Benzinga MRK
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.